BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12643345)

  • 1. Hypertrophic cardiomyopathy: from gene defect to clinical disease.
    Chung MW; Tsoutsman T; Semsarian C
    Cell Res; 2003 Feb; 13(1):9-20. PubMed ID: 12643345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder.
    Doolan A; Nguyen L; Semsarian C
    Heart Lung Circ; 2004 Mar; 13(1):15-25. PubMed ID: 16352163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes, calcium and modifying factors in hypertrophic cardiomyopathy.
    Tsoutsman T; Lam L; Semsarian C
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):139-45. PubMed ID: 16445713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
    Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
    Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
    Alcalai R; Seidman JG; Seidman CE
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis.
    Cam FS; Güray M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):327-30. PubMed ID: 15590362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of inherited cardiomyopathies.
    Fatkin D; Graham RM
    Physiol Rev; 2002 Oct; 82(4):945-80. PubMed ID: 12270949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy: current understanding and treatment objectives.
    Soor GS; Luk A; Ahn E; Abraham JR; Woo A; Ralph-Edwards A; Butany J
    J Clin Pathol; 2009 Mar; 62(3):226-35. PubMed ID: 18930982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
    Brito D; Madeira H
    Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
    Bos JM; Towbin JA; Ackerman MJ
    J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of hypertrophic cardiomyopathy.
    Hughes SE
    Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.